On the other hand, the increase in CSF Aβ40 levels, traced by pathological amyR, associates with higher levels of soluble hyperphosphorylated tau, higher AD-related burden, and a widespread pattern of FDG hypometabolism. This evidence concerns the gene MAPT and Alzheimer disease.